Jakafi
Jakafi Approved To Treat Chronic GVHD in Adults and Children
The FDA approved ruxolitinib (Jakafi, Incyte) for chronic graft-versus-host disease after failure of one or two ...
OCTOBER 15, 2021
FDA Approves Jakafi to Treat Acute GVHD
The FDA granted a new indication for Jakafi to treat steroid-refractory acute graft-versus-host disease in adults ...
MAY 28, 2019
Load more